Given the continued toll of respiratory conditions, America's biopharmaceutical researchers are dedicated to advancing science and developing solutions to address asthma, allergies and COPD.
With more than 100 medicines for respiratory diseases currently in development and 49 medicines for asthma alone, the future has never been brighter.
Steve Yancey and his team work to discover new and better treatments that address the needs of severe asthma patients.
Living with severe asthma is a full-time job, and it has impacted nearly every area of Donna’s life.
Biologics could bring an end to today’s “one size fits all” approach to treating asthma says René van der Merwe.
Gil shares his experience living with severe asthma, and the impact new treatments have on his life.
Dr. Kolbeck led a team of researchers to develop what has become AstraZeneca’s first respiratory biologic treatment.
Subscribe to receive the latest in medical innovation, treatment insights, and inspirational stories.